Skip to main content
Merck & Co., Inc.
Healthcare · Drug Manufacturers - General
Made on Aug 1, 2026
Price at call $130.23
6-month call Neutral -4.8%
Target by Feb 2027 $124.00
Great value below $100.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -4.8% to $124.00
Predicted High $133.10 at 1 month
Predicted Low $124.00 at 6 months
Max Drawdown (predicted) -4.8%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 1, 2026 12:45 am
Neutral MRK trends range-bound to $124.00 (-4.8% from $130.23) by Feb 2027. ride-then-fade
ThesisMRK trades well above composite fair value ($95.69) but momentum is strong (21% trailing 6mo) and earnings on 8/3 has a 3/3 beat streak. Expect a post-print pop or hold, then gradual value gravity pulling toward the anchored-PE zone as the multi-month picture reasserts.
Invalidated ifAn earnings miss or guidance cut on 8/3 dropping shares below $120, or a breakout above $140 on pipeline catalyst, would falsify.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $130.23 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 1, 2026 $130.23 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 15, 2026 $122.50–$137.96 typical range · internal point $132.80 ±5.9% 6/10 Earnings beat streak likely extends, modest post-print lift
What actually happened: closed $135.85 on Aug 14, 2026 = +4.3% vs the call (predicted +2.0%)  ·  direction HIT (called flat, was flat)  ·  off by 2.3 pp  ·  accuracy 9/10  ·  typical range ±5.9%: inside the band  ·  S&P +4.0% over the same window — lagged it
1 month Sep 1, 2026 $119.02–$141.44 typical range · internal point $133.10 ±8.6% 5/10 Post-earnings drift holds with defensive bid intact
2 months Oct 1, 2026 $131.50 +1.0% 5/10 Momentum cools, valuation overhang starts pressing
3 months Nov 1, 2026 $129.00 -0.9% 5/10 Value gravity toward anchored-PE begins asserting
4 months Dec 1, 2026 $127.20 -2.3% 4/10 Year-end positioning trims extended defensives
5 months Jan 1, 2027 $125.50 -3.6% 4/10 Convergence toward deterministic baseline endpoint
6 months Feb 1, 2027 $124.00 -4.8% 3/10 Fair-value pull dominates as sentiment stays neutral

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $125.69 (-3.5%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$130.23
Composite fair value$95.69
Signal-adjusted fair value$92.84
DCF fair value$98.71
Anchored-PE fair value$132.14
Buy-below (value lens)$100.00
Value net score-68
Value confidence7 / 10
Quality net score+48
Memo confidence8 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 29.2%  3m 29.8%  6m 27.9%  
Daily σ (realism noise)1.9%
Beta vs S&P 500 1m -0.37  3m -0.35  5m 0.10  
Trailing 6-month return21.4%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 1, 2026 freshest MRK-20260801-001034-debd
ext-forensic-memo Aug 1, 2026 freshest ext-MRK-20260801-003431-3051
ext-lens-quality Aug 1, 2026 freshest ext-MRK-20260801-003431-3051
ext-lens-sentiment Aug 1, 2026 freshest ext-MRK-20260801-003431-3051
ext-lens-value Aug 1, 2026 freshest ext-MRK-20260801-003431-3051
scenario-valuation Aug 1, 2026 freshest MRK-20260801-001034-debd
valuation-synthesis Aug 1, 2026 freshest MRK-20260801-001034-debd

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 1, 2026 v0.6.0 Neutral $130.23 $124.00 -4.8% Feb 2027 viewing
Jun 30, 2026 v0.3.0 Bull $129.38 $137.30 +6.1% Dec 2026 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.